Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,045
datasets available to search
ShareScore release 0.9.0
Dataset results
1,045 results for “neoadjuvant chemotherapy”
Internal Mammary Lymph Nodes Irradiation in High-risk Breast Cancer After Neoadjuvant Chemotherapy
ClinicalTrials.gov study NCT06559696. IPD Sharing: NO. Countries: 1. Publications: 0.
Neoadjuvant Sugemalimab + Chemotherapy Followed by Adjuvant Sugemalimab for Patients With Resectable Stage II-IIIA Non-small-cell Lung Cancer Patients
ClinicalTrials.gov study NCT06987734. IPD Sharing: Not stated. Countries: 1. Publications: 0.
DCE-MRI Guided Neoadjuvant Chemotherapy for Borderline Resectable Pancreatic Cancer
ClinicalTrials.gov study NCT06173310. IPD Sharing: NO. Countries: 1. Publications: 0.
MRI Radiomics Assessing Neoadjuvant Chemotherapy in Breast Cancer to Predict Lymph Node Metastasis and Prognosis(RBC-02)
ClinicalTrials.gov study NCT04004559. IPD Sharing: NO. Countries: 1. Publications: 0.
QL1706 Plus Chemotherapy as Neoadjuvant Therapy for Locally Advanced Cervical Cancer: A Phase II Trial
ClinicalTrials.gov study NCT07286253. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Neoadjuvant Chemotherapy Plus Pyrotinib and Trastuzumab for HER2-positive Breast Cancer (NEOTORCH-BREAST05)
ClinicalTrials.gov study NCT06832904. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Mathematical Modeling to Predict Response to Neoadjuvant Chemotherapy in Breast Cancer
ClinicalTrials.gov study NCT03983538. IPD Sharing: NO. Countries: 1. Publications: 0.
Neoadjuvant Immunotherapy and Chemotherapy Followed by Surgery in Unresectable Stage Ⅲ NSCLC
ClinicalTrials.gov study NCT04943029. IPD Sharing: NO. Countries: 1. Publications: 0.
A Prospective Cohort Study of Neoadjuvant Chemotherapy Plus Sintillumab in the Treatment of Resectable NSCLC
ClinicalTrials.gov study NCT06485557. IPD Sharing: NO. Countries: 0. Publications: 0.
Additional 4 Cycles of Cisplatin (CDDP4) in Patients With Triple Negative Breast Cancer for Neoadjuvant Chemotherapy
ClinicalTrials.gov study NCT02001519. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Quality of Life in Advanced Gastric Cancer Patients Receiving Neoadjuvant Chemotherapy
ClinicalTrials.gov study NCT04408859. IPD Sharing: NO. Countries: 1. Publications: 0.
Imaging for Response Assessment of Neoadjuvant Chemotherapy in Primary Breast Cancer (GALADON)
ClinicalTrials.gov study NCT01690325. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Neoadjuvant and Adjuvant Durvalumab in Combination With Neoadjuvant Chemotherapy in Patients With Operable Urothelial Cancer.
ClinicalTrials.gov study NCT03406650. IPD Sharing: NO. Countries: 2. Publications: 0.
Molecular Profiling After Neoadjuvant Chemotherapy for Triple-negative Breast Cancer
ClinicalTrials.gov study NCT04362462. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Neoadjuvant Chemotherapy Sequentially Combined with Sintilimab in Resectable EGFR-Mutant NSCLC
ClinicalTrials.gov study NCT06688656. IPD Sharing: NO. Countries: 1. Publications: 0.
Neoadjuvant Chemotherapy With PD-1 Inhibitors Combined With SIB-IMRT in the Treatment of Locally Advanced Rectal Cancer
ClinicalTrials.gov study NCT06017583. IPD Sharing: NO. Countries: 1. Publications: 0.
Chemotherapy Followed by Surgery and Neoadjuvant Hemothoracic Intensity Modified Radiation Therapy (IMRT) for Patients With Malignant Pleural Mesothelioma
ClinicalTrials.gov study NCT02613312. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Comparative Efficiency of Three Regimen, CEFci, CEF and EC as Neoadjuvant Chemotherapy for Primary Breast Cancer
ClinicalTrials.gov study NCT01199432. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Neoadjuvant Chemotherapy for Locally Advanced Thymic Cancer
ClinicalTrials.gov study NCT01312324. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Tislelizumab With Chemotherapy or Radiation for Neoadjuvant Therapy of Esophageal Squamous Cell Carcinoma (TINES)
ClinicalTrials.gov study NCT05603065. IPD Sharing: NO. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.